UNSPSC 51191570: Xipamide

This classification denotes a diuretic with the molecular formula C15H15ClN2O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4S9EY0NUEC, chemically known as 4-chloro-5-sulfamoyl-2,6-salicyloxylidide but generally known as xipamide, which bears US NIH Compound Identifier 26618. European Medicines Agency schedules Xipamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00116MIG.

UNSPSC 51191570 Xipamide is a Commodity code that in recent state and local activity spans pharmaceutical and chemical supply for healthcare and municipal infrastructure rather than xipamide specifically. The code appears in solicitations for parenteral pharmaceutical products, wastewater treatment chemicals, and water pollution control supplies—scope that diverges substantially from the code's nominal pharmaceutical name. State and local issuing bodies currently soliciting under this code include state correctional departments, municipal utilities, and county infrastructure authorities. The Washington State Department of Corrections is actively procuring parenteral products and services including parenteral nutrition solutions, intravenous solutions, and controlled substances for incarcerated individuals across eight facilities in three regions (West, Central, and East), with responses due October 7, 2026 and pre-bid conference on September 23, 2026. The City of Meriden, Connecticut solicited sodium bisulfite chemical supply for municipal water pollution control operations under IFB B027-15 with responses due July 29, 2026. Broward County, Florida issued an RFI on DeZurik/APCO valves and repair services for wastewater treatment, with responses due September 29, 2026, to evaluate availability of alternatives to the current sole-source provider.

Recent activity concentrates in Florida, Washington, and Connecticut. The Washington State Department of Corrections opportunity anticipates awarding up to three contractors per region with an initial contract term from November 26, 2026 through June 30, 2030 and pricing held firm for two years; small business (25%), minority-owned business (10%), women-owned business (6%), and veteran-owned business (5%) participation goals apply under Chapter 39.19 RCW. The Meriden chemical supply required General Liability coverage of $1 million to $2 million and performance and payment bonds. The Broward County RFI requires vendors to demonstrate authorized supplier status, SCADA-compatible valve engineering capability, experience with municipal wastewater facilities, preventive maintenance programs, and documented spare-parts response commitments for compliance-driven environments. The code shows limited recent activity and the few opportunities present suggest state and local procurement activity tagged to this code does not align consistently with xipamide pharmaceuticals.